Elanco Animal Health Inc
ELAT
New York Stock Exchange21.32
USD
+0.22
- -
CIK
0001739104
ISIN
US28414H2022
CUSIP
28414H202
Return %
Stock
S&P500
1Y
-51.87
19.25
3Y
-58.29
65.11
5Y
-14.82
72.21
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- United States of America
- IPO Date
- Jan 30, 2020
- CIK
- 0001739104
- Similar Companies
- Business
- Elanco Animal Health Inc (NYSE: ELAT) develops, manufactures, and markets products for companion and food animals worldwide. The company offers pharmaceuticals, parasiticide products, vaccines, and therapeutics for pets including dogs, cats, and horses; antibiotics, parasiticides, vaccines, and enzymes for livestock such as ruminants, poultry, and swine; as well as medicated feed additives, nutritional feed products, and diagnostics. Elanco operates in over 90 countries, with a primary focus on North America, Europe, Latin America, and Asia-Pacific, targeting veterinarians, livestock producers, and pet owners. Founded in 2013 as a spin-off from Eli Lilly and Company, the company is headquartered in Greenfield, Indiana.